Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Being.Patient
Cardiovascular Drugs, Like Statins, May Reduce Alzheimer’s Risk
Could Psychedelics Help Treat Alzheimer’s?
Boosting the Brain’s Metabolism to Fight Alzheimer’s
Study: Early Onset Alzheimer’s Diagnoses Have Tripled
Meet PSEN1: A Newly Discovered Genetic Biomarker for Alzheimer’s
Obesity Linked to Premature Aging and Alzheimer’s in New Study
Researchers ‘Reset’ Immune Cells to Prevent Inflammation in TBI and Dementia
B. Smith, Model and Restaurateur, Dies From Alzheimer’s at Age 70
Clearing Tau in Frontotemporal Dementia: Researchers Identify Target Protein
Rising Drug Prices Make Alzheimer’s Patients Less Likely to Fill Prescriptions
Having Both Alzheimer’s and Diabetes May Increase Risk of Stroke
New Alzheimer’s Trial Aims to Defeat Amyloid Before Symptoms Develop
Another Alzheimer’s Trial Cancelled: Lilly, Roche Drugs Fail to Reduce Beta-Amyloid
FDA Approves Insomnia Drug, Suvorexant, for Alzheimer’s Patients
The Link Between High Blood Pressure and Dementia
Previous
41
42
43
Next
Page load link
Go to Top